Inactive Instrument

Press Releases STALLERGENES

Equities

FR0000065674

End-of-day quote Euronext Paris Other stock markets
- ^EUR	-

2014

DBV TECHNOLOGIES : French developer of 'peanut allergy patch' makes U.S. debut

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

STALLERGENES : GREER ANNOUNCES ITS 2016 FINANCIAL CALENDAR	16-02-22	PU
STALLERGENES : MICHELE ANTONELLI APPOINTED PRESIDENT OF STALLERGENES SAS & EXECUTIVE VP HEAD OF EUROPE & ROW	16-02-10	PU
STALLERGENES : MICHELE ANTONELLI APPOINTED PRESIDENT OF STALLERGENES SAS AND EXECUTIVE VP, HEAD OF EUROPE & REST OF WORLD	16-02-10	PU
STALLERGENES : MICHELE ANTONELLI APPOINTED PRESIDENT OF STALLERGENES SAS AND EXECUTIVE VICE PRESIDENT, HEAD OF EUROPE & REST OF WORLD	16-02-10	PU
STALLERGENES : GREER ANNOUNCES RESUMPTION OF MANUFACTURING AT ITS ANTONY PLANT	16-02-01	PU
STALLERGENES : TIBOR NEMES APPOINTED GLOBAL HEAD OF TECHNICAL OPERATIONS	16-02-01	PU
STALLERGENES : RECALL OF ALLERGY IMMUNOTHERAPY PRODUCTS	15-12-07	PU
STALLERGENES : ANNOUNCES THE LAUNCH OF ACTAIR® IN JAPAN	15-11-19	PU
STALLERGENES : Michele Antonelli appointed as Executive Vice President, Head of International Operations	15-11-10	PU
STALLERGENES : Introducing a new global allergy company	15-11-10	PU
STALLERGENES : Ares Allergy Holdings plc becomes Stallergenes Greer plc	15-11-10	PU
STALLERGENES : Development of our House Dust Mite sublingual immunotherapy tablet	15-11-10	PU
Stallergenes : is pleased to see the mobile allergen exposure chamber at the 2015 EAACI congress, Barcelona	15-06-08	PU
Stallergenes : continues its international expansion with the opening of an affiliate in Canada.	14-10-24	PU
Stallergenes : sales reach €45.7 million in Q3 2014; Oralair® achieves market leadership in France; Continued expansion of international markets (up 33%)	14-10-23	PU
STALLERGENES : Half-year revenues and results	14-07-24	PU
Stallergenes : welcomes Fleur Pellerin, Secretary of State for Foreign Trade to its principal site in Antony, Hauts-de-Seine, France.	14-07-08	PU
Stallergenes : to be present at the 3rd annual Citi European healthcare conference on June 20, 2014	14-06-06	PU
STALLERGENES : Industrial consortium announces its support for GA²LEN’s developement of mobile environmental exposure chambers	14-05-08	PU
Stallergenes : announes FDA approval of Oralair®, the first sublingual immunotherapy tablet for the treatment of grass pollen allergy	14-04-02	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases STALLERGENES

Equities

FR0000065674

Press Releases

Filters